Cargando…

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease

Background and aims: lipoprotein(a) (Lp(a)) is a genetically determined risk factor for coronary artery disease and its complications, although data on the association with other vascular beds and the severity of atherosclerosis is limited. The aim of this study was to evaluate the association of at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tmoyan, Narek A., Afanasieva, Olga I., Ezhov, Marat V., Klesareva, Elena A., Balakhonova, Tatiana V., Pokrovsky, Sergei N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911372/ https://www.ncbi.nlm.nih.gov/pubmed/33513851 http://dx.doi.org/10.3390/jcdd8020011

Ejemplares similares

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
por: Ezhov, Marat V., et al.
Publicado: (2021)

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
por: Chubykina, Uliana V., et al.
Publicado: (2022)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
por: Afanasieva, Olga, et al.
Publicado: (2020)

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2023)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
por: Afanasieva, Olga I., et al.
Publicado: (2021)

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
por: Burdeynaya, Anna L., et al.
Publicado: (2023)

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels
por: Ezhov, Marat, et al.
Publicado: (2019)

The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis
por: Filatova, Anastasiia Yu., et al.
Publicado: (2023)

Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases
por: Ezhov, Marat V., et al.
Publicado: (2021)

Asymptomatic polyvascular atherosclerotic disease requires a complex management strategy – case report and review of the literature
por: Jurcut, R, et al.
Publicado: (2009)

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
por: Ilina, Larisa N., et al.
Publicado: (2022)

Comprehensive Assessment of Polyvascular Atherosclerosis
por: Nakanishi, Rine, et al.
Publicado: (2018)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels
por: Funabashi, Sayaka, et al.
Publicado: (2022)

Calling and Phasing of Single-Nucleotide and Structural Variants of the LDLR Gene Using Oxford Nanopore MinION
por: Nazarenko, Maria S., et al.
Publicado: (2023)

Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease
por: Peterson, Benjamin E., et al.
Publicado: (2023)

Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
por: Greco, Maria Francesca, et al.
Publicado: (2020)

Polyvascular Disease and the Incidence of Cancer in Patients with Coronary Artery Disease
por: Suzuki, Makoto, et al.
Publicado: (2022)

Associations Between Polyvascular Disease and Stroke Recurrence in Patients With Lacunar Stroke
por: Ma, Lin, et al.
Publicado: (2021)

Preclinical carotid atherosclerosis as an indicator of polyvascular disease: a narrative review
por: Poredos, Pavel, et al.
Publicado: (2021)

Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
por: Alkhalil, Mohammad, et al.
Publicado: (2021)

Prognostic Role of Polyvascular Involvement in Patients with Symptomatic Peripheral Artery Disease
por: Adam, Luise, et al.
Publicado: (2023)

Polyvascular Disease in Patients Presenting with Acute Coronary Syndrome: Its Predictors and Outcomes
por: Al Thani, Hassan, et al.
Publicado: (2012)

Risk Factors for Polyvascular Involvement in Patients With Peripheral Artery Disease: A Mendelian Randomization Study
por: Dikilitas, Ozan, et al.
Publicado: (2020)

Asymptomatic Polyvascular Abnormalities in Community (APAC) Study in China: Objectives, Design and Baseline Characteristics
por: Zhou, Yong, et al.
Publicado: (2013)

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction
por: Fujisue, Koichiro, et al.
Publicado: (2019)

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
por: Ivanova, Ekaterina A., et al.
Publicado: (2017)

Correction: Asymptomatic Polyvascular Abnormalities in Community (APAC) Study in China: Objectives, Design and Baseline Characteristics
por: Zhou, Yong, et al.
Publicado: (2014)

Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease
por: Szarek, Michael, et al.
Publicado: (2022)

A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation
por: Duivenvoorden, Raphaël, et al.
Publicado: (2014)

Carotid Atherosclerosis, Cerebrospinal Fluid Pressure, and Retinal Vessel Diameters: The Asymptomatic Polyvascular Abnormalities in Community Study
por: Yang, Jing Yan, et al.
Publicado: (2016)

Association of Polyvascular Disease and Elevated Interleukin-6 With Outcomes in Acute Ischemic Stroke or Transient Ischemic Attack
por: Tian, Ye, et al.
Publicado: (2021)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome
por: Ezhov, Marat V., et al.
Publicado: (2023)

Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease
por: Jönelid, Birgitta, et al.
Publicado: (2019)

Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access
por: Yamawaki, Masahiro, et al.
Publicado: (2021)

Serum lipoprotein (a) and atherosclerotic changes in hemodialysis patients
por: Rafieian-Kopaei, Mahmoud, et al.
Publicado: (2013)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7hs0puiavnpilt2qclum4g64il